Drug intelligence / Profile preview

GliSODin

Development stage
Unknown
Lead developer
Isocell
Modality
Recombinant Proteins and Enzymes, Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

GliSODin is a patented, orally active nutritional supplement. Its main active ingredient is superoxide dismutase (SOD), an antioxidant enzyme, derived from a specific, non-GMO cantaloupe melon extract (*Cucumis melo* L.). [1, 11, 21] This SOD extract is combined with gliadin, a wheat protein, which protects the enzyme from degradation in the digestive tract, ensuring its bioavailability. [3, 13] Developed and manufactured by the French company ISOCELL, GliSODin works by stimulating the body's own antioxidant defense system, rather than acting as a direct, single-use antioxidant. [3, 8, 14] It has been clinically studied for various applications, including reducing oxidative stress, protecting skin from UV damage, improving skin conditions like melasma and vitiligo, supporting immune function, and aiding in sports recovery. [1, 4, 10, 15] It is marketed as a nutricosmetic and dietary supplement. [4, 11]

Brand names
GliSODinGliSODin V-SODMelon GliSODin
Other names
SOD-gliadin complexgastro-protected superoxide dismutasemelon superoxide dismutase-gliadin
02

Targets

Misfolded SOD1GPX4 (Glutathione peroxidase 4)Neuraminidase

Beyond the preview

Go deeper on GliSODin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GliSODin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call